Apteka Olmed releases clinical overview on curcumin use

Polish pharmaceutical retailer Olmed has published a clinical overview focused on curcumin, the active compound derived from turmeric. Authored by pharmacist Edyta Olszewska, the report provides a breakdown of the substance's reported properties, usage guidelines, and clinical contraindications for consumers.

The document distinguishes between culinary turmeric and concentrated curcumin, noting that while the compound is widely marketed as a dietary supplement, users must be aware of potential interactions and safety constraints. The guide serves to educate the public on when and how to appropriately integrate such supplements into a health regimen.

This release aligns with Olmed’s digital strategy to provide pharmacy-led health education alongside its retail operations. As the market for dietary supplements grows, the firm is positioning its platform as a source of verified pharmaceutical information.